HC Wainwright & Co. Reiterates Alimera Sciences (ALIM) Buy Recommendation

Fintel reports that on May 25, 2023, HC Wainwright & Co. reiterated coverage of Alimera Sciences (NASDAQ:ALIM) with a Buy recommendation. Analyst Price Forecast Suggests 187.80% Upside

admin